
In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified a possible new drug target for treating the disease. This time, the treatment doesn’t include chemotherapy.
T-cell acute lymphoblastic leukemia is one of the most common and aggressive chil...
More